Determinants of hydroxyurea use among doctors, nurses and sickle cell disease patients in Nigeria.

<h4>Background</h4>Hydroxyurea (HU) is an evidence-based therapy that is currently the most effective drug for sickle cell disease (SCD). HU is widely used in high-income countries with consequent reduction of morbidity and mortality. In Nigeria, HU is prescribed by physicians while nurses are mainl...

全面介紹

書目詳細資料

Principais autores:	Hezekiah Alkali Isa, Uche Nnebe-Agumadu, Maxwell M Nwegbu, Emmanuel C Okocha, Reuben I Chianumba, Biobele J Brown, Samuel A Asala, Emmanuel Peprah, Obiageli E Nnodu
格式:	Artigo
語言:	Inglês
出版:	Public Library of Science (PLoS) 2022-01-01
叢編:	PLoS ONE
在線閱讀:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0276639&type=printable
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!